BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21751494)

  • 1. [A dyslipidemia animal model induced by poloxamer 407 in golden hamsters and pilot study on the mechanism].
    Liu Q; Liu SN; Li LY; Chen ZY; Lei L; Zhang N; Shen ZF
    Yao Xue Xue Bao; 2011 Apr; 46(4):406-11. PubMed ID: 21751494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhizic acid attenuates the expression of HMG-CoA reductase mRNA in high fructose diet induced dyslipidemic hamsters.
    Maurya SK; Srivastava AK
    Prague Med Rep; 2011; 112(1):29-37. PubMed ID: 21470496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
    Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
    Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists.
    Wang PR; Guo Q; Ippolito M; Wu M; Milot D; Ventre J; Doebber T; Wright SD; Chao YS
    Eur J Pharmacol; 2001 Sep; 427(3):285-93. PubMed ID: 11567659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats.
    Ji G; Zhao X; Leng L; Liu P; Jiang Z
    Lipids Health Dis; 2011 Jan; 10():23. PubMed ID: 21269482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
    Wilcox LJ; Barrett PH; Huff MW
    J Lipid Res; 1999 Jun; 40(6):1078-89. PubMed ID: 10357840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooked rice prevents hyperlipidemia in hamsters fed a high-fat/cholesterol diet by the regulation of the expression of hepatic genes involved in lipid metabolism.
    Choi WH; Gwon SY; Ahn J; Jung CH; Ha TY
    Nutr Res; 2013 Jul; 33(7):572-9. PubMed ID: 23827132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial.
    Black RN; Ennis CN; Young IS; Hunter SJ; Atkinson AB; Bell PM
    J Diabetes Complications; 2014; 28(3):323-7. PubMed ID: 24560135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sepsis syndrome stimulates proximal tubule cholesterol synthesis and suppresses the SR-B1 cholesterol transporter.
    Zager RA; Johnson AC; Hanson SY
    Kidney Int; 2003 Jan; 63(1):123-33. PubMed ID: 12472775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia.
    Chong T; Naples M; Federico L; Taylor D; Smith GJ; Cheung RC; Adeli K
    Atherosclerosis; 2006 Mar; 185(1):21-31. PubMed ID: 16002078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha.
    Huang XS; Zhao SP; Bai L; Hu M; Zhao W; Zhang Q
    Br J Pharmacol; 2009 Oct; 158(3):706-12. PubMed ID: 19694729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of lipid metabolism and gene expression by fenofibrate in hamsters.
    Guo Q; Wang PR; Milot DP; Ippolito MC; Hernandez M; Burton CA; Wright SD; Chao Y
    Biochim Biophys Acta; 2001 Oct; 1533(3):220-32. PubMed ID: 11731332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis.
    Dong Z; Shi H; Zhao M; Zhang X; Huang W; Wang Y; Zheng L; Xian X; Liu G
    Metabolism; 2018 Jun; 83():245-255. PubMed ID: 29526535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.
    Nissen SE; Nicholls SJ; Wolski K; Howey DC; McErlean E; Wang MD; Gomez EV; Russo JM
    JAMA; 2007 Mar; 297(12):1362-73. PubMed ID: 17384435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig.
    Conde K; Roy S; Freake HC; Newton RS; Fernandez ML
    Lipids; 1999 Dec; 34(12):1327-32. PubMed ID: 10652993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hyperlipidemic and insulin sensitizing activities of fenofibrate reduces aortic lipid deposition in hyperlipidemic Golden Syrian hamster.
    Srivastava RA; He S
    Mol Cell Biochem; 2010 Dec; 345(1-2):197-206. PubMed ID: 20740305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity.
    Mangaloglu L; Cheung RC; Van Iderstine SC; Taghibiglou C; Pontrelli L; Adeli K
    Metabolism; 2002 Apr; 51(4):409-18. PubMed ID: 11912545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atorvastatin on lipid metabolism in normolipidemic and hereditary hyperlipidemic, non-laying hens.
    Elkin RG; Zhong Y; Donkin SS; Hengstschläger-Ottnad E; Schneider WJ
    Comp Biochem Physiol B Biochem Mol Biol; 2006 Mar; 143(3):319-29. PubMed ID: 16413806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.
    Chen Y; Ku H; Zhao L; Wheeler DC; Li LC; Li Q; Varghese Z; Moorhead JF; Powis SH; Huang A; Ruan XZ
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):365-76. PubMed ID: 24233489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.